Eltoprazine Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEltoprazine Hydrochloride
Drug Alias Nameeltoprazinum依托拉嗪依托拉嗪盐酸盐eltoprazinaeltoprazine +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsSchizophreniaCognition DisordersDyskinesias +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPsychogenics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmarantus Bioscience Holdings Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersDyskinesias +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia